In the third session from the Platelet Reactivity Testing Round Table, the panel discuss treatment options for high-risk PCI patients. Among the many fascinating points discussed in this session are a number of key issues including:
TimeDiscussion Point
01'10
Evidence regarding antiplatelet drug response
03'45
Treatment options for antiplatelet therapy in the cathlab
08'10
Interpreting the finding of ARCTIC study
15'14
Bleeding risk in patients with complex disease
17'40
Is there a role for platelet function testing in assessing compliance?
18'30
Value of platelet function testing for assessing whether there is a drug response
22'30
Is the P2'i'12 assay robust enough to titrate a response?
This round table discussion is intended for an international audience, specifically interventional cardiologists, interventional radiologists and aligned healthcare professional involved with antiplatelet therapy.
The Round Table Event was supported by Accumetrics.
Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives: